Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

60 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Nintedanib in NSCLC: evidence to date and place in therapy.
Bronte G, Passiglia F, Galvano A, Barraco N, Listì A, Castiglia M, Rizzo S, Fiorentino E, Bazan V, Russo A. Bronte G, et al. Among authors: castiglia m. Ther Adv Med Oncol. 2016 May;8(3):188-97. doi: 10.1177/1758834016630976. Epub 2016 Feb 16. Ther Adv Med Oncol. 2016. PMID: 27239237 Free PMC article. Review.
Monitoring blood biomarkers to predict nivolumab effectiveness in NSCLC patients.
Passiglia F, Galvano A, Castiglia M, Incorvaia L, Calò V, Listì A, Mazzarisi S, Perez A, Gallina G, Rizzo S, Soto Parra H, Bazan V, Russo A. Passiglia F, et al. Among authors: castiglia m. Ther Adv Med Oncol. 2019 Apr 16;11:1758835919839928. doi: 10.1177/1758835919839928. eCollection 2019. Ther Adv Med Oncol. 2019. PMID: 31019571 Free PMC article.
Analysis of systemic inflammatory biomarkers in neuroendocrine carcinomas of the lung: prognostic and predictive significance of NLR, LDH, ALI, and LIPI score.
Galvano A, Peri M, Guarini AA, Castiglia M, Grassadonia A, De Tursi M, Irtelli L, Rizzo S, Bertani A, Gristina V, Barraco N, Russo A, Natoli C, Bazan V. Galvano A, et al. Among authors: castiglia m. Ther Adv Med Oncol. 2020 Aug 11;12:1758835920942378. doi: 10.1177/1758835920942378. eCollection 2020. Ther Adv Med Oncol. 2020. PMID: 32849916 Free PMC article.
Is there any room for PD-1 inhibitors in combination with platinum-based chemotherapy as frontline treatment of extensive-stage small cell lung cancer? A systematic review and meta-analysis with indirect comparisons among subgroups and landmark survival analyses.
Gristina V, Galvano A, Castellana L, Insalaco L, Cusenza S, Graceffa G, Iacono F, Barraco N, Castiglia M, Perez A, Rizzo S, Russo A, Bazan V. Gristina V, et al. Among authors: castiglia m. Ther Adv Med Oncol. 2021 Jul 21;13:17588359211018018. doi: 10.1177/17588359211018018. eCollection 2021. Ther Adv Med Oncol. 2021. PMID: 34646363 Free PMC article.
The prognostic impact of tumor mutational burden (TMB) in the first-line management of advanced non-oncogene addicted non-small-cell lung cancer (NSCLC): a systematic review and meta-analysis of randomized controlled trials.
Galvano A, Gristina V, Malapelle U, Pisapia P, Pepe F, Barraco N, Castiglia M, Perez A, Rolfo C, Troncone G, Russo A, Bazan V. Galvano A, et al. Among authors: castiglia m. ESMO Open. 2021 Jun;6(3):100124. doi: 10.1016/j.esmoop.2021.100124. Epub 2021 Apr 30. ESMO Open. 2021. PMID: 33940346 Free PMC article. Review.
Are erlotinib and gefitinib interchangeable, opposite or complementary for non-small cell lung cancer treatment? Biological, pharmacological and clinical aspects.
Bronte G, Rolfo C, Giovannetti E, Cicero G, Pauwels P, Passiglia F, Castiglia M, Rizzo S, Vullo FL, Fiorentino E, Van Meerbeeck J, Russo A. Bronte G, et al. Among authors: castiglia m. Crit Rev Oncol Hematol. 2014 Feb;89(2):300-13. doi: 10.1016/j.critrevonc.2013.08.003. Epub 2013 Aug 28. Crit Rev Oncol Hematol. 2014. PMID: 24041630
Stabilizing versus destabilizing the microtubules: a double-edge sword for an effective cancer treatment option?
Fanale D, Bronte G, Passiglia F, Calò V, Castiglia M, Di Piazza F, Barraco N, Cangemi A, Catarella MT, Insalaco L, Listì A, Maragliano R, Massihnia D, Perez A, Toia F, Cicero G, Bazan V. Fanale D, et al. Among authors: castiglia m. Anal Cell Pathol (Amst). 2015;2015:690916. doi: 10.1155/2015/690916. Epub 2015 Sep 21. Anal Cell Pathol (Amst). 2015. PMID: 26484003 Free PMC article. Review.
Triple negative breast cancer: shedding light onto the role of pi3k/akt/mtor pathway.
Massihnia D, Galvano A, Fanale D, Perez A, Castiglia M, Incorvaia L, Listì A, Rizzo S, Cicero G, Bazan V, Castorina S, Russo A. Massihnia D, et al. Among authors: castiglia m. Oncotarget. 2016 Sep 13;7(37):60712-60722. doi: 10.18632/oncotarget.10858. Oncotarget. 2016. PMID: 27474173 Free PMC article. Review.
60 results